Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Concord, California
  • +73 more
Nov 9, 2023

Type 2 Diabetes Trial in Worldwide (Orforglipron, Semaglutide)

Not yet recruiting
  • Type 2 Diabetes
  • Phoenix, Arizona
  • +135 more
Sep 13, 2023

Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +91 more
Jul 25, 2023

Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)

Not yet recruiting
  • Overweight or Obesity
  • +2 more
  • Canoga Park, California
  • +19 more
Jun 30, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Pelham, Alabama
  • +135 more
May 15, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Type 2 Diabetes, T2D Trial in Worldwide (LY3209590, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • T2D
  • Birmingham, Alabama
  • +71 more
Jan 26, 2023

Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Active, not recruiting
  • Type 2 Diabetes
  • Little Rock, Arkansas
  • +129 more
Jan 19, 2023

Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Recruiting
  • Diabetes
  • Type 2 Diabetes
  • Escondido, California
  • +128 more
Jan 18, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)

Recruiting
  • Type 2 Diabetes
  • Cooper City, Florida
  • +43 more
Jan 17, 2023

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Lispro (U100), Insulin Glargine (U100))

Completed
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +134 more
Nov 22, 2022

Type 2 Diabetes, Type 2 Diabetes Treated With Insulin Trial in Worldwide (LY3209590, Insulin Lispro (U100), Insulin Glargine

Not yet recruiting
  • Type 2 Diabetes
  • Type 2 Diabetes Treated With Insulin
  • Hamden, Connecticut
  • +82 more
Aug 8, 2022

Type 2 Diabetes Trial in Houston (Stable isotope infusion, oral glucose ingestion, intravenous arginine bolus)

Not yet recruiting
  • Type 2 Diabetes
  • Stable isotope infusion, oral glucose ingestion, intravenous arginine bolus
  • Houston, Texas
    Texas Children's Hospital / Baylor College of Medicine
Aug 4, 2022

Type 2 Diabetes Trial in United States (Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing Sham (Sham))

Completed
Has Results
  • Type 2 Diabetes
  • Duodenal Mucosal Resurfacing (DMR)
  • Duodenal Mucosal Resurfacing Sham (Sham)
  • Orlando, Florida
  • +5 more
Jun 30, 2022

Type 2 Diabetes Trial in Worldwide (LY3502970, Dulaglutide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Anaheim, California
  • +43 more
Jun 21, 2022

Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Birmingham, Alabama
  • +74 more
Apr 18, 2022

Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),

Completed
  • Type 2 Diabetes
  • Comparative Effectiveness of Glycemia-lowering Medications
  • Sulfonylurea (glimepiride)
  • +3 more
  • Birmingham, Alabama
  • +35 more
Apr 13, 2022

Obesity, Type 2 Diabetes Trial in Houston (SSC Program, Written Handouts)

Completed
  • Obesity
  • Type 2 Diabetes
  • SSC Program
  • Written Handouts
  • Houston, Texas
  • +1 more
Apr 11, 2022

Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, Lantus®)

Completed
Has Results
  • Type 2 Diabetes
  • Chandler, Arizona
  • +119 more
Mar 1, 2022

Type 2 Diabetes Trial in Puerto Rico, United States (LY900014, Insulin Glargine)

Completed
  • Type 2 Diabetes
  • Concord, California
  • +31 more
Feb 24, 2022

Type 2 Diabetes Trial in Puerto Rico, United States (LY3437943, Dulaglutide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +42 more
Feb 18, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +126 more
Jan 21, 2022

Type 2 Diabetes Trial in Australia, China, United States (INS068 injection, Insulin Degludec)

Active, not recruiting
  • Type 2 Diabetes
  • INS068 injection
  • Insulin Degludec
  • Huntington Park, California
  • +32 more
Jan 27, 2022

Type 2 Diabetes Trial in United States (BT-001, Physician-guided Standard of Care for type 2 diabetes)

Active, not recruiting
  • Type 2 Diabetes
  • BT-001
  • Physician-guided Standard of Care for type 2 diabetes
  • San Francisco, California
  • +5 more
Jan 13, 2022

TODAY2 Phase 2 Follow-up

Completed
  • Type 2 Diabetes
  • TODAY cohort
  • Los Angeles, California
  • +14 more
Jul 29, 2021